Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Tulevski, II; Groenink, M; van der Wall, EE; van Veldhuisen, DJ; Boomsma, F; Stoker, J; Hirsch, A; Lemkes, JS; Mulder, BJM
   Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction
   HEART
   
   I.I. Tulevski et al., "Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction", HEART, 86(1), 2001, pp. 27-30
2. Tulevski, II; Hirsch, A; Sanson, BJ; Romkes, H; van der Wall, EE; van Veldhuisen, DJ; Buller, HR; Mulder, BJM
   Increased brain natriuretic peptide as a marker for right ventricular dysfunction in acute pulmonary embolism
   THROMBOSIS AND HAEMOSTASIS
   
   I.I. Tulevski et al., "Increased brain natriuretic peptide as a marker for right ventricular dysfunction in acute pulmonary embolism", THROMB HAEM, 86(5), 2001, pp. 1193-1196
3. Oosterhof, T; Groenink, M; Hulsmans, FJ; Mulder, BJM; van der Wall, EE; Smit, R; Hennekam, RCM
   Quantitative assessment of dural ectasia as a marker for Marfan syndrome
   RADIOLOGY
   
   T. Oosterhof et al., "Quantitative assessment of dural ectasia as a marker for Marfan syndrome", RADIOLOGY, 220(2), 2001, pp. 514-518
4. Groenink, M; de Roos, A; Mulder, BJM; Verbeeten, B; Timmermans, J; Zwinderman, AH; Spaan, JAE; van der Wall, EE
   Biophysical properties of the normal-sized aorta in patients with Marfan syndrome: Evaluation with MR flow mapping
   RADIOLOGY
   
   M. Groenink et al., "Biophysical properties of the normal-sized aorta in patients with Marfan syndrome: Evaluation with MR flow mapping", RADIOLOGY, 219(2), 2001, pp. 535-540
5. van Karnebeek, CDM; Naeff, MSJ; Mulder, BJM; Hennekam, RCM; Offringa, M
   Natural history of cardiovascular manifestations in Marfan syndrome
   ARCHIVES OF DISEASE IN CHILDHOOD
   
   C.D.M. van Karnebeek et al., "Natural history of cardiovascular manifestations in Marfan syndrome", ARCH DIS CH, 84(2), 2001, pp. 129-137
6. Tulevski, II; Lee, PL; Groenink, M; van der Wall, EE; Stoker, J; Pieper, PG; Romkes, H; Hirsch, A; Mulder, BJM
   Dobutamine-induced increase of right ventricular contractility without increased stroke volume in adolescent patients with transposition of the greatarteries: Evaluation with magnetic resonance imaging
   INTERNATIONAL JOURNAL OF CARDIAC IMAGING
   
   I.I. Tulevski et al., "Dobutamine-induced increase of right ventricular contractility without increased stroke volume in adolescent patients with transposition of the greatarteries: Evaluation with magnetic resonance imaging", INT J CAR I, 16(6), 2000, pp. 471-478
7. Meijboom, LJ; Groenink, M; van der Wall, EE; Romkes, H; Stoker, J; Mulder, BJM
   Aortic root asymmetry in Marfan patients; evaluation by magnetic resonanceimaging and comparison with standard echocardiography
   INTERNATIONAL JOURNAL OF CARDIAC IMAGING
   
   L.J. Meijboom et al., "Aortic root asymmetry in Marfan patients; evaluation by magnetic resonanceimaging and comparison with standard echocardiography", INT J CAR I, 16(3), 2000, pp. 161-168
8. Groenink, M; Lohuis, TAJ; Tijssen, JGP; Naeff, MSJ; Hennekam, RCM; van der Wall, EE; Mulder, BJM
   Survival and complication free survival in Marfan's syndrome: implicationsof current guidelines
   HEART
   
   M. Groenink et al., "Survival and complication free survival in Marfan's syndrome: implicationsof current guidelines", HEART, 82(4), 1999, pp. 499-504
9. van Nienwenhuizen, RC; Peters, M; Lubbers, LJ; Trip, MD; Tijssen, JGP; Mulder, BJM
   Abnormalities in liver function and coagulation profile following the Fontan procedure
   HEART
   
   R.C. van Nienwenhuizen et al., "Abnormalities in liver function and coagulation profile following the Fontan procedure", HEART, 82(1), 1999, pp. 40-46
10. Groenink, M; Mulder, BJM; van der Wall, EE
    Value of magnetic resonance imaging in functional assessment of baffle obstruction after the Mustard procedure
    JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE
    
    M. Groenink et al., "Value of magnetic resonance imaging in functional assessment of baffle obstruction after the Mustard procedure", J CARD M RE, 1(1), 1999, pp. 49-51
11. Tan, ES; van der Meer, J; de Kam, PJ; Dunselman, PHJM; Mulder, BJM; Ascoop, CAPL; Pfisterer, M; Lie, KI
    Worse clinical outcome but similar graft patency in women versus men one year after coronary artery bypass graft surgery owing to an excess of exposed risk factors in women
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    E.S. Tan et al., "Worse clinical outcome but similar graft patency in women versus men one year after coronary artery bypass graft surgery owing to an excess of exposed risk factors in women", J AM COL C, 34(6), 1999, pp. 1760-1768
12. Groenink, M; Langerak, SE; Vanbavel, E; van der Wall, EE; Mulder, BJM; van der Wal, AC; Spaan, JAE
    The influence of aging and aortic stiffness on permanent dilation and breaking stress of the thoracic descending aorta
    CARDIOVASCULAR RESEARCH
    
    M. Groenink et al., "The influence of aging and aortic stiffness on permanent dilation and breaking stress of the thoracic descending aorta", CARDIO RES, 43(2), 1999, pp. 471-480
13. Voskuil, M; Hazekamp, MG; Kroft, LJM; Lubbers, WJ; Ottenkamp, J; van der Wall, EE; Zwinderman, KH; Mulder, BJM
    Postsurgical course of patients with congenitally corrected transposition of the great arteries
    AMERICAN JOURNAL OF CARDIOLOGY
    
    M. Voskuil et al., "Postsurgical course of patients with congenitally corrected transposition of the great arteries", AM J CARD, 83(4), 1999, pp. 558-562
14. GROENINK M; ROZENDAAL L; NAEFF MSJ; HENNEKAM RCM; HART AAM; VANDERWALL EE; MULDER BJM
    MARFAN-SYNDROME IN CHILDREN AND ADOLESCENTS - PREDICTIVE AND PROGNOSTIC VALUE OF AORTIC ROOT-GROWTH FOR SCREENING FOR AORTIC COMPLICATIONS
    HEART
    
    M. Groenink et al., "MARFAN-SYNDROME IN CHILDREN AND ADOLESCENTS - PREDICTIVE AND PROGNOSTIC VALUE OF AORTIC ROOT-GROWTH FOR SCREENING FOR AORTIC COMPLICATIONS", HEART, 80(2), 1998, pp. 163-169
15. ROZENDAAL L; GROENINK M; NAEFF MSJ; HENNEKAM RCM; HART AAM; VANDERWALL EE; MULDER BJM
    MARFAN-SYNDROME IN CHILDREN AND ADOLESCENTS - AN ADJUSTED NOMOGRAM FOR SCREENING AORTIC ROOT DILATATION
    HEART
    
    L. Rozendaal et al., "MARFAN-SYNDROME IN CHILDREN AND ADOLESCENTS - AN ADJUSTED NOMOGRAM FOR SCREENING AORTIC ROOT DILATATION", HEART, 79(1), 1998, pp. 69-72
16. VANNIEUWENHUIZEN R; PETERS M; LUBBERS LJ; TRIP MD; TIJSSEN JGP; MULDER BJM
    ABNORMALITIES IN LIVER-FUNCTION AND COAGULATION PROFILE AFTER THE FONTAN PROCEDURE
    Circulation
    
    R. Vannieuwenhuizen et al., "ABNORMALITIES IN LIVER-FUNCTION AND COAGULATION PROFILE AFTER THE FONTAN PROCEDURE", Circulation, 98(17), 1998, pp. 3251-3251
17. GROENINK M; DEROOS A; MULDER BJM; SPAAN JAE; VANDERWALL EE
    CHANGES IN AORTIC DISTENSIBILITY AND PULSE-WAVE VELOCITY ASSESSED WITH MAGNETIC-RESONANCE-IMAGING FOLLOWING BETA-BLOCKER THERAPY IN THE MARFAN-SYNDROME
    The American journal of cardiology
    
    M. Groenink et al., "CHANGES IN AORTIC DISTENSIBILITY AND PULSE-WAVE VELOCITY ASSESSED WITH MAGNETIC-RESONANCE-IMAGING FOLLOWING BETA-BLOCKER THERAPY IN THE MARFAN-SYNDROME", The American journal of cardiology, 82(2), 1998, pp. 203-208
18. GROENINK M; DEROOS A; MULDER BJM; SPAAN JAE; VANDERWALL EE
    DETECTION OF SEGMENTAL AORTIC DISTENSIBILITY ALTERATIONS BY MAGNETIC-RESONANCE VELOCITY MAPPING IN THE MARFAN-SYNDROME
    Journal of the American College of Cardiology
    
    M. Groenink et al., "DETECTION OF SEGMENTAL AORTIC DISTENSIBILITY ALTERATIONS BY MAGNETIC-RESONANCE VELOCITY MAPPING IN THE MARFAN-SYNDROME", Journal of the American College of Cardiology, 29(2), 1997, pp. 23107-23107
19. VOSKUIL M; KROFT LJM; HAZEKAMP MG; LUBBERS WJ; OTTENKAMP J; WALL EE; MULDER BJM
    NATURAL-HISTORY AND POSTSURGICAL FOLLOW-UP IN PATIENTS WITH CONGENITALLY CORRECTED TRANSPOSITION OF THE GREAT-ARTERIES
    Circulation
    
    M. Voskuil et al., "NATURAL-HISTORY AND POSTSURGICAL FOLLOW-UP IN PATIENTS WITH CONGENITALLY CORRECTED TRANSPOSITION OF THE GREAT-ARTERIES", Circulation, 96(8), 1997, pp. 534-534
20. GROENINK M; DEROOS A; MULDER BJM; VANDERWALL EE
    THE MARFAN-SYNDROME - EFFECT OF BETA-BLOCKERS ON ENTIRE AORTIC DISTENSIBILITY ASSESSED WITH MAGNETIC-RESONANCE-IMAGING
    Circulation
    
    M. Groenink et al., "THE MARFAN-SYNDROME - EFFECT OF BETA-BLOCKERS ON ENTIRE AORTIC DISTENSIBILITY ASSESSED WITH MAGNETIC-RESONANCE-IMAGING", Circulation, 96(8), 1997, pp. 703-703
21. VANDERMEER J; HILLEGE HL; ASCOOP CAPL; DUNSELMAN PHJM; MULDER BJM; VANOMMEN GVA; PFISTERER M; VANGILST WH; LIE KI
    APROTININ IN AORTOCORONARY BYPASS-SURGERY - INCREASED RISK OF VEIN-GRAFT OCCLUSION AND MYOCARDIAL-INFARCTION - SUPPORTIVE EVIDENCE FROM A RETROSPECTIVE STUDY
    Thrombosis and haemostasis
    
    J. Vandermeer et al., "APROTININ IN AORTOCORONARY BYPASS-SURGERY - INCREASED RISK OF VEIN-GRAFT OCCLUSION AND MYOCARDIAL-INFARCTION - SUPPORTIVE EVIDENCE FROM A RETROSPECTIVE STUDY", Thrombosis and haemostasis, 75(1), 1996, pp. 1-3
22. VANDERMEER J; DELARIVIERE AB; VANGILST WH; HILLEGE HL; PFISTERER M; KOOTSTRA GJ; DUNSELMAN PHJM; MULDER BJM; LIE KI
    EFFECTS OF LOW-DOSE ASPIRIN (50-MG DAY), LOW-DOSE ASPIRIN PLUS DIPYRIDAMOLE, AND ORAL ANTICOAGULANT AGENTS AFTER INTERNAL MAMMARY ARTERY BYPASS-GRAFTING - PATENCY AND CLINICAL OUTCOME AT 1 YEAR/
    Journal of the American College of Cardiology
    
    J. Vandermeer et al., "EFFECTS OF LOW-DOSE ASPIRIN (50-MG DAY), LOW-DOSE ASPIRIN PLUS DIPYRIDAMOLE, AND ORAL ANTICOAGULANT AGENTS AFTER INTERNAL MAMMARY ARTERY BYPASS-GRAFTING - PATENCY AND CLINICAL OUTCOME AT 1 YEAR/", Journal of the American College of Cardiology, 24(5), 1994, pp. 1181-1188
23. VANDERMEER J; DELARIVIERE AB; VANGILST WH; HILLEGE HL; PFISTERER M; KOOTSTRA GJ; DUNSELMAN PHJM; MULDER BJM; LIE KI
    EFFECTS OF LOW-DOSE ASPIRIN (50-MG DAY), LOW-DOSE ASPIRIN PLUS DIPYRIDAMOLE, AND ORAL ANTICOAGULANT AGENTS AFTER INTERNAL MAMMARY ARTERY BYPASS-GRAFTING - PATENCY AND CLINICAL OUTCOME AT 1 YEAR/
    Journal of the American College of Cardiology
    
    J. Vandermeer et al., "EFFECTS OF LOW-DOSE ASPIRIN (50-MG DAY), LOW-DOSE ASPIRIN PLUS DIPYRIDAMOLE, AND ORAL ANTICOAGULANT AGENTS AFTER INTERNAL MAMMARY ARTERY BYPASS-GRAFTING - PATENCY AND CLINICAL OUTCOME AT 1 YEAR/", Journal of the American College of Cardiology, 24(5), 1994, pp. 1181-1188
24. VANDERMEER J; HILLEGE HL; DUNSELMAN PHJM; MULDER BJM; MICHELS HR; BUSER PT; VANGILST WH; LIE KI
    ORAL ANTICOAGULATION IN THE PREVENTION OF ONE-YEAR VEIN GRAFT OCCLUSION AFTER AORTOCORONARY BYPASS-SURGERY - OPTIMAL THERAPEUTIC RANGE AND PRACTICAL LIMITATIONS
    Thrombosis and haemostasis
    
    J. Vandermeer et al., "ORAL ANTICOAGULATION IN THE PREVENTION OF ONE-YEAR VEIN GRAFT OCCLUSION AFTER AORTOCORONARY BYPASS-SURGERY - OPTIMAL THERAPEUTIC RANGE AND PRACTICAL LIMITATIONS", Thrombosis and haemostasis, 72(5), 1994, pp. 676-681
25. MULDER BJM; VANDERDOEF RM; VANDERWALL EE; TIJSSEN JGP; PIEK JJ; VANDERMEER J; DUNNING AJ
    EFFECT OF VARIOUS ANTITHROMBOTIC REGIMENS (ASPIRIN, ASPIRIN PLUS DIPYRIDAMOLE, ANTICOAGULANTS) ON THE FUNCTIONAL STATUS OF PATIENTS AND GRAFTS ONE-YEAR AFTER CORONARY-ARTERY BYPASS-GRAFTING
    European heart journal
    
    B.J.M. Mulder et al., "EFFECT OF VARIOUS ANTITHROMBOTIC REGIMENS (ASPIRIN, ASPIRIN PLUS DIPYRIDAMOLE, ANTICOAGULANTS) ON THE FUNCTIONAL STATUS OF PATIENTS AND GRAFTS ONE-YEAR AFTER CORONARY-ARTERY BYPASS-GRAFTING", European heart journal, 15(8), 1994, pp. 1129-1134
26. VANDERMEER J; HILLEGE HL; VANGILST WH; DELARIVIERE AB; DUNSELMAN PHJM; FIDLER V; KOOTSTRA GJ; MULDER BJM; PFISTERER M; LIE KI; MEIJLER FL; ASCOOP CAPL; DUNNING AJ; MICHELS HR; DEMEDINA EOR; WELLENS HJJ; ARNTZENIUS AC; LUBSEN J; SCHUILENBERG RM; SKOTNICKI SH; DEFEYTER PJ; HOORNTJE JCA; VISSER FC; VANDIJK RB; DENHEYER P; JANSSEN J; VANOMMEN GVA; BAR FWHM; HAUER RNW; VIERSMA JW; FANGGIDAEJ D; LIEM AL; TEUBEN JHM; VANDERVEEN HF; TIJSSEN JGP; VUIJK M; DEJONGSTE MJL; EIJGELAAR A; VANDERDOEF R; PIEK J; MEYNE NG; GIN RMTY; VERMEULEN FE; BUSER P; BURKART F; GRADEL E; BONNIER JJRM; BAVINCK JH; SCHMIDT H; NUSE J; SEGGEWISS K; POSIVAL H; GLEICHMANN U; KORFER R; TERRES W; BLEIFELD W; KALMAR P; PENN OEK; WEVER E; HITCHCOCK JF
    A COMPARISON OF INTERNAL MAMMARY ARTERY AND SAPHENOUS-VEIN GRAFTS AFTER CORONARY-ARTERY BYPASS-SURGERY - NO DIFFERENCE IN 1-YEAR OCCLUSION RATES AND CLINICAL OUTCOME
    Circulation
    
    J. Vandermeer et al., "A COMPARISON OF INTERNAL MAMMARY ARTERY AND SAPHENOUS-VEIN GRAFTS AFTER CORONARY-ARTERY BYPASS-SURGERY - NO DIFFERENCE IN 1-YEAR OCCLUSION RATES AND CLINICAL OUTCOME", Circulation, 90(5), 1994, pp. 2367-2374
27. VANDERMEER J; HILLEGE HL; ASCOOP CAPL; DUNSELMAN PHJM; MULDER BJM; PFISTERER M
    RISK-BENEFIT RATIO OF APROTININ THERAPY IN CORONARY-ARTERY BYPASS-SURGERY
    Circulation
    
    J. Vandermeer et al., "RISK-BENEFIT RATIO OF APROTININ THERAPY IN CORONARY-ARTERY BYPASS-SURGERY", Circulation, 90(4), 1994, pp. 640-640
28. VANDERMEER J; HILLEGE HL; ASCOOP CAPL; DUNSELMAN PHJM; MULDER BJM; PFISTERER M
    RISK-BENEFIT RATIO OF APROTININ THERAPY IN CORONARY-ARTERY BYPASS-SURGERY
    Circulation
    
    J. Vandermeer et al., "RISK-BENEFIT RATIO OF APROTININ THERAPY IN CORONARY-ARTERY BYPASS-SURGERY", Circulation, 90(4), 1994, pp. 640-640